These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16159932)

  • 21. Sarcoidosis and primary hyperparathyroidism simultaneously occurring in a hypercalcemic patient.
    Hassan S; Amer S; Swamy V; Rao S
    Indian J Endocrinol Metab; 2012 Nov; 16(6):1062-3. PubMed ID: 23226677
    [No Abstract]   [Full Text] [Related]  

  • 22. Granulomatous infiltration of a parathyroid adenoma presenting as primary hyperparathyroidism in a woman: a case report.
    Anaforoğlu I; Siviloğlu C; Livaoğlu A; Algün E
    J Med Case Rep; 2010 Dec; 4():400. PubMed ID: 21143903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressive effects of 1,4-dihydroxy-2-naphthoic acid administration on bone resorption.
    Matsubara M; Yamachika E; Tsujigiwa H; Mizukawa N; Ueno T; Murakami J; Ishida N; Kaneda Y; Shirasu N; Takagi S
    Osteoporos Int; 2010 Aug; 21(8):1437-47. PubMed ID: 19813044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tubular calcium reabsorption and other aspects of calcium homeostasis in primary and secondary hyperparathyroidism.
    Phelps KR; Stote KS; Mason D
    Clin Nephrol; 2014 Aug; 82(2):83-91. PubMed ID: 24985952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
    Lim V; Clarke BL
    J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.
    Kinoshita Y; Taguchi M; Takeshita A; Miura D; Tomikawa S; Takeuchi Y
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D physiology.
    Lips P
    Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
    Shah VN; Shah CS; Bhadada SK; Rao DS
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):797-803. PubMed ID: 24382124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis.
    Goltzman D; Mannstadt M; Marcocci C
    Front Horm Res; 2018; 50():1-13. PubMed ID: 29597231
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.